Minnesota Mining and Manufacturing Company v. Johnson & Johnson Orthopaedics, Inc.

976 F.2d 1559, 1992 WL 247410
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 30, 1992
Docket91-1428
StatusPublished
Cited by213 cases

This text of 976 F.2d 1559 (Minnesota Mining and Manufacturing Company v. Johnson & Johnson Orthopaedics, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Minnesota Mining and Manufacturing Company v. Johnson & Johnson Orthopaedics, Inc., 976 F.2d 1559, 1992 WL 247410 (Fed. Cir. 1992).

Opinion

RICH, Circuit Judge.

Johnson & Johnson Orthopaedics, Inc. (JJO) appeals from the judgment of the United States District Court for the District of Minnesota, Fourth Division, Civil Action No. 4-86-359, holding JJO liable for infringement of claims 1-4 and 8 of U.S. Patent No. 4,502,479, issued to Garwood et al. in 1985 (the Garwood patent); willful infringement of claim 1 of U.S. Patent No. 4,609,578, issued to Reed in 1986 (the Reed patent); willful infringement of claims 12 *1563 and 17 of U.S. Patent No. 4,667,661, issued to Scholz et al. in 1987 (the Scholz patent); and willful infringement of claims 3, 4, 10, 11, 12, 18, 21 and 43 of U.S. Patent No. 4,774,937, issued to Scholz et al. in 1988 (the Scholz II patent). The patents relate to orthopedic casting tapes and, more specifically, to resin based casting systems which have replaced plaster casts. The district court awarded Minnesota Mining And Manufacturing Co. (3M) damages of $53,636,348 and prejudgment interest in the amount of $9,525,000 and also awarded double damages based on JJO’s willful infringement. We affirm.

I.

BACKGROUND

A. The District Court Opinion

This case originally involved four U.S. patents and was tried before a Special Master, Janice M. Symchych (the Master). The lawsuit was filed by 3M against JJO alleging willful infringement of the four, above-mentioned patents, misappropriation of trade secrets, theft, and receipt of stolen property. JJO counterclaimed for violation of antitrust laws and a declaratory judgment of patent invalidity and unenforce-ability on the four patents, as well as damages for fraudulent procurement and claims under Minnesota law for fraud, unfair competition and deceptive trade practices.

The trial lasted thirty-four days, involved the testimony of 32 witnesses and over one thousand evidentiary exhibits, and resulted in 435 findings of fact and 86 conclusions of law made by the Master. The Master’s findings of fact/conclusions of law, and memorandum opinion are set forth at Minnesota Mining And Mfg. Co. v. Johnson & Johnson Orthopaedics, Inc., Civil Action No. 4-86-359,1991 WL 441901, 1991 U.S. Dist. LEXIS 11451 (D.Minn.-Fourth Div. April 30, 1991) and 1991 U.S. Dist. LEXIS 14823 (D.Minn.-Fourth Div. April 30, 1991), respectively. The Master’s decision was reviewed by the district court in connection with the parties’ motions related to the Master’s report. These motions included JJO’s opposition to the Master’s report.

The district court subsequently issued an opinion dated July 26, 1991, 1991 WL 340579, based on the Master’s findings of fact, conclusions of law, and memorandum opinion holding that the Garwood, Reed, Scholz and Scholz II patents are valid and enforceable, and that JJO infringed claims of all four patents. All of JJO’s counterclaims were dismissed with prejudice. Damages and interest as above stated were awarded. Finally, the district court enjoined JJO from continued infringement of the patents in suit.

Since the district court adopted the Master’s findings,' we refer to the district court’s findings in this opinion as the Master’s findings.

On appeal, JJO challenges the Master’s findings that: (1) the Scholz and Garwood patents are valid and infringed; (2) there was no inequitable conduct committed by 3M during the prosecution of the Scholz and Reed patent applications before the U.S. Patent and Trademark Office (PTO); (4) JJO willfully infringed the Scholz and Reed patents; and (5) 3M was entitled to the award of damages amounting to $53,-636,348 (before doubling).

B. General Technology

The inventions involved in this case relate to synthetic orthopedic casting tapes which have replaced plaster of paris bandages which had been the preferred means used to immobilize broken or fractured bones for over a century. Plaster casting tapes are activated by dipping and squeezing them in water which causes them to become creamy and smooth. In this state, the bandages can easily be rubbed and smoothed in order to shape the cast around the area of a broken or fractured bone. The bandages are then allowed to harden to form a solid cast.

Plaster of Paris casts were originally preferred because they are easy to apply and mold around broken limbs. However, plaster casts suffer from several drawbacks because they are slow to harden, heavy, relatively nonporous, do not allow *1564 the skin to “breathe,” and readily break down when exposed to water.

During the 1970s several attempts were made in the casting field to develop a synthetic casting product that would retain the advantages of plaster (i.e., its slipperiness and smoothability) while overcoming its drawbacks by being lightweight, porous, quick to harden, and water resistant. Two main components were involved in these developments. The first was a substrate or backing which comes in the form of a knitted or woven fabric (i.e., a scrim) cut into narrow strips or tapes; the second was a resin which is coated on or impregnated in the substrate and hardens after it is activated.

Three major players in the synthetic casting industry — 3M, JJO, and Cutter Biomedical (Cutter), a U.S. subsidiary of Bayer A.G. (Bayer), a German Chemical Company — evolved in the market, each hoping to develop a synthetic cast that would replace plaster of pans as the industry standard. Ultimately, 3M and JJO became the industry leaders, obtaining a combined market share of about 70-90% from 1985 to 1991. However, based on the Garwood, Reed, Scholz, and Scholz II inventions, 3M emerged as the undisputed industry leader, controlling approximately half the market from 1985 to 1991. With each new invention, 3M introduced a new casting product. JJO would then copy the product and introduce a corresponding competitive casting product. The level of competition rose to the point where, in November, 1985, JJO obtained trade secrets stolen from 3M by Philip Stegora, a 3M chemist. These were samples of 3M’s slippery resin product disclosed in the Scholz and Scholz II patents, which had not yet issued. JJO analyzed the samples and later filed a patent application based on technology culled therefrom.

C.The Garwood Patent

The Garwood patent discloses an improved orthopedic casting material, invented by Dr. Donald C. Garwood and Dr. Shiraz A. Kathiriya, which is strong, lightweight, porous, and quick curing. The material is obtained by combining knit fiberglass fabric from 0.020-0.045 of an inch thick and having 20-200 mesh openings per square inch with a water-curable polyurethane prepolymer resin described in U.S. Patent No. 4,376,438, issued March 15, 1983 to Straube et al. (the Straube patent).

D. The Reed Patent

The Reed patent discloses a method for obtaining an improved resin coated casting tape, invented by Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Masimo Corp. v. Philips Electronics North America Corp.
742 F. Supp. 2d 492 (D. Delaware, 2010)
Mitsubishi Chemical Corp. v. Barr Laboratories, Inc.
718 F. Supp. 2d 382 (S.D. New York, 2010)
Ormco Corp. v. ALIGN TECHNOLOGY, INC.
653 F. Supp. 2d 1016 (C.D. California, 2009)
Hitachi Koki Co., Ltd. v. Doll
620 F. Supp. 2d 4 (District of Columbia, 2009)
Muniauction, Inc. v. Thomson Corp.
502 F. Supp. 2d 477 (W.D. Pennsylvania, 2007)
In Re Omeprazole Patent Litigation
490 F. Supp. 2d 381 (S.D. New York, 2007)
Sanofi-Synthelabo v. Apotex Inc.
488 F. Supp. 2d 317 (S.D. New York, 2006)
Medtronic Xomed, Inc. v. Gyrus Ent LLC
440 F. Supp. 2d 1300 (M.D. Florida, 2006)
Mangosoft, Inc. v. Oracle Corp.
421 F. Supp. 2d 392 (D. New Hampshire, 2006)
Daiichi Pharmaceutical Co., Ltd. v. Apotex, Inc.
380 F. Supp. 2d 478 (D. New Jersey, 2005)
Network Appliance, Inc. v. Bluearc Corp.
374 F. Supp. 2d 825 (N.D. California, 2005)
Cargill, Inc. v. Sears Petroleum & Transport Corp.
334 F. Supp. 2d 197 (N.D. New York, 2004)
Sharper Image Corp. v. Honeywell International Inc.
222 F.R.D. 621 (N.D. California, 2004)
IXYS Corp. v. Advanced Power Technology, Inc.
321 F. Supp. 2d 1133 (N.D. California, 2004)
Bristol-Myers Squibb Co. v. Andrx Pharmaceuticals, Inc.
343 F. Supp. 2d 1124 (S.D. Florida, 2004)
Convolve, Inc. v. Compaq Computer Corp.
224 F.R.D. 98 (S.D. New York, 2004)
Teleflex Inc. v. KSR International Co.
298 F. Supp. 2d 581 (E.D. Michigan, 2003)
Merck & Co., Inc. v. TEVA PHARMACEUTICALS USA
288 F. Supp. 2d 601 (D. Delaware, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
976 F.2d 1559, 1992 WL 247410, Counsel Stack Legal Research, https://law.counselstack.com/opinion/minnesota-mining-and-manufacturing-company-v-johnson-johnson-cafc-1992.